Survey of British Pathologists' performance of mesothelioma post-mortems

Pathology Research and Practice

Volumn 206, Issue 3, 2010, Pages 174-179

  Goldstein, R ^a   Hasleton, P S ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Diagnosis; Immunohistochemistry; Mesothelioma; Post mortem

Indexed keywords

ASBESTOS; CALRETININ; CYTOKERATIN;

ARTICLE; AUTOPSY; CLINICAL COMPETENCE; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFORMATION DISSEMINATION; MESOTHELIOMA; PATHOLOGIST; QUESTIONNAIRE; SAMPLING; UNITED KINGDOM;

AUTOPSY; DIAGNOSIS; GREAT BRITAIN; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MESOTHELIOMA; PATHOLOGY; PLEURAL NEOPLASMS; QUESTIONNAIRES; TUMOR MARKERS, BIOLOGICAL;

EID: 76949102317     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2009.11.002     Document Type: Article

References (15)

1. Wagner J.C., Sleggs C.A., and Marchand P. Diffuse pleural mesotheliomas and asbestos exposure in a north western Cape province. Br. J. Ind. Med. 17 (1960) 260-271
2. Robinson B.W., Musk A.W., and Lake RA. Malignant mesothelioma. Lancet 366 (2005) 397-408
3. Hodgson J.T., McELvenny D.M., Darnton A.J., Price M.J., and Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br. J. Cancer 92 (2005) 587-593
4. Roberts F., McCall A.E., and Burnett RA. Malignant mesothelioma: a comparison of biopsy and post-mortem material by light microscopy and immunohistochemistry. J. Clin. Pathol. 54 (2001) 766-770
5. King J.E., Thatcher N., Pickering C.A., and Hasleton PS. Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology 48 (2006) 223-232
6. Craighead J.E., Abraham J.L., Churg A., et al. The pathology of asbestos-associated diseases of the lung and pleural cavities: Report of the Pneumoconiosis Committee of the American College of Pathologists and National Institute of Occupational Safety and Health. Arch. Pathol. Lab. Med. 106 (1982) 544-596
7. Hasleton P. Pleural disease. In: Hasleton P. (Ed). Spencer's Pathology of the Lung. 5th ed. (1996), McGraw-Hill, New York 1131-1210
8. Independent Review Group on Retention of Organs at Post mortem: Final Report, 2001. http://www.sehd.scot.nhs.uk/scotorgrev/Final%20Report/ropm-00.htm (accessed November 6th 2006).
9. Gore R.B., Ducie C.M., Lukza A.R. 30 years of mesothelioma in Barrow in Furness. Thorax 1998; 53, (Suppl. 4), A29 (p. 21) [abstract].
10. Attanoos RL., and Gibbs AR. Pathology of malignant mesothelioma. Histopathology 30 (1997) 403-418
11. Attanoos RL., Griffin A., and Gibbs AR. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2. Histopathology 43 (2003) 231-238
12. Lucas D.R., Pass I.H., Madan S.K., et al. Sarcomatoid mesothelioma and its histopathological mimics: a comparative immunohistochemical study. Histopathology 42 (2003) 270-279
13. Attanoos R.L., Dojcinov S.D., Webb R., and Gibbs AR. Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms. Histopathology 37 (2000) 224-231
14. The Coroner's Autopsy: Do we deserve better?A report of the National Confidential Enquiry into Patient Outcome and Death (2006). http://www.ncepod.org.uk/2006.htm (accessed November 6th 2006)
15. Human Tissue Act, 2004. http://www.opsi.gov.uk/acts/acts2004/20040030.htm (accessed November 6th 2006)